GENEREX GETS APPROVAL FOR ORAL-LYN PHASE III TRIAL

摘要

Generex Biotechnology Corporation(Nasdaq:GNBT),Worcester,Mass.,a leader in drug delivery for metabolic diseases through the inner lining of the mouth,announced that on January 22,2008 the Ministry of Health of the Ukraine issued an approval letter for the conduct of a Phase III clinical trial protocol for Generex Oral-lyn(tm)at eight clinical sites located in the Ukraine.